- Home
- SCKT vs NCNA Comparison
SCKT vs NCNA Comparison
Compare SCKT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- NCNA
- Stock Information
- Founded
- SCKT 1992
- NCNA 1997
- Country
- SCKT United States
- NCNA United Kingdom
- Employees
- SCKT N/A
- NCNA N/A
- Industry
- SCKT Computer Manufacturing
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- NCNA Health Care
- Exchange
- SCKT Nasdaq
- NCNA Nasdaq
- Market Cap
- SCKT 8.4M
- NCNA 7.6M
- IPO Year
- SCKT 1995
- NCNA 2017
- Fundamental
- Price
- SCKT $1.02
- NCNA $6.88
- Analyst Decision
- SCKT
- NCNA
- Analyst Count
- SCKT 0
- NCNA 0
- Target Price
- SCKT N/A
- NCNA N/A
- AVG Volume (30 Days)
- SCKT 14.2K
- NCNA 768.1K
- Earning Date
- SCKT 10-23-2025
- NCNA 11-24-2025
- Dividend Yield
- SCKT N/A
- NCNA N/A
- EPS Growth
- SCKT N/A
- NCNA N/A
- EPS
- SCKT N/A
- NCNA N/A
- Revenue
- SCKT $16,710,984.00
- NCNA N/A
- Revenue This Year
- SCKT $8.62
- NCNA N/A
- Revenue Next Year
- SCKT N/A
- NCNA N/A
- P/E Ratio
- SCKT N/A
- NCNA N/A
- Revenue Growth
- SCKT N/A
- NCNA N/A
- 52 Week Low
- SCKT $0.85
- NCNA $2.78
- 52 Week High
- SCKT $1.72
- NCNA $446.00
- Technical
- Relative Strength Index (RSI)
- SCKT 46.41
- NCNA 74.46
- Support Level
- SCKT $1.01
- NCNA $3.79
- Resistance Level
- SCKT $1.04
- NCNA $5.07
- Average True Range (ATR)
- SCKT 0.02
- NCNA 0.56
- MACD
- SCKT -0.00
- NCNA 0.18
- Stochastic Oscillator
- SCKT 29.82
- NCNA 99.06
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.